Pharmacotherapeutic follow-up to pediatric patients aged up to 12 years in the pathology of atopic dermatitis - integrative review
| Autor(a) principal: | |
|---|---|
| Data de Publicação: | 2021 |
| Outros Autores: | |
| Tipo de documento: | Artigo |
| Idioma: | por |
| Título da fonte: | Research, Society and Development |
| Texto Completo: | https://rsdjournal.org/index.php/rsd/article/view/22715 |
Resumo: | Objective: to analyze the impacts on the quality of life of patients aged up to 12 years with atopic dermatitis and which are the main drugs used. Methods: An integrative literature review was used, using as a guiding question; “What are the impacts on the quality of life of patients aged up to 12 years with atopic dermatitis and what are the main drugs used?”. Results: the article resulted in the selection of 11 articles, of which more than half deal with reduced quality and the rest with new AD treatments. Conclusion: It can be seen a decrease in the quality of life of children and parents, also causing psychological and social damage. New alternatives such as Duplilumabe have been obtaining good results as an alternative to the treatment of AD is used when AD is not controlled by other conventional treatments or when in some cases conventional medications are not indicated. Herbal medicine demonstrated effectiveness in preventing AD, with Aloe Vera standing out due to its benefits. |
| id |
UNIFEI_88db6a9c6967729a4e02bb1e49348f0d |
|---|---|
| oai_identifier_str |
oai:ojs.pkp.sfu.ca:article/22715 |
| network_acronym_str |
UNIFEI |
| network_name_str |
Research, Society and Development |
| repository_id_str |
|
| spelling |
Pharmacotherapeutic follow-up to pediatric patients aged up to 12 years in the pathology of atopic dermatitis - integrative reviewSeguimiento farmacoterapéutico de pacientes pediátricos de hasta 12 años en patología de la dermatitis atópica - revisión integradoraAcompanhamento farmacoterapêutico ao paciente pediátrico na faixa etária de até 12 anos na patologia de dermatite atópica - revisão integrativaAtopic dermatitesNew drugsQuality of life.Dermatitis atópicaNuevas drogasCalidad de vida.Dermatite atópicaNovos medicamentosQualidade de vida. Objective: to analyze the impacts on the quality of life of patients aged up to 12 years with atopic dermatitis and which are the main drugs used. Methods: An integrative literature review was used, using as a guiding question; “What are the impacts on the quality of life of patients aged up to 12 years with atopic dermatitis and what are the main drugs used?”. Results: the article resulted in the selection of 11 articles, of which more than half deal with reduced quality and the rest with new AD treatments. Conclusion: It can be seen a decrease in the quality of life of children and parents, also causing psychological and social damage. New alternatives such as Duplilumabe have been obtaining good results as an alternative to the treatment of AD is used when AD is not controlled by other conventional treatments or when in some cases conventional medications are not indicated. Herbal medicine demonstrated effectiveness in preventing AD, with Aloe Vera standing out due to its benefits.Objetivo: analizar los impactos en la calidad de vida de los pacientes de hasta 12 años con dermatitis atópica y cuáles son los principales fármacos utilizados. Métodos: Se utilizó una revisión integradora de la literatura, utilizando como pregunta orientadora; “¿Cuáles son los impactos en la calidad de vida de los pacientes de hasta 12 años con dermatitis atópica y cuáles son los principales fármacos utilizados?”. Resultados: el artículo resultó en la selección de 11 artículos, de los cuales más de la mitad tratan de calidad reducida y el resto de nuevos tratamientos para la EA. Conclusión: Se observa una disminución en la calidad de vida de los niños y los padres, provocando además daños psicológicos y sociales. Nuevas alternativas como Duplilumabe han ido obteniendo buenos resultados como alternativa al tratamiento de la EA que se utiliza cuando la EA no está controlada por otros tratamientos convencionales o cuando en algunos casos no están indicados los medicamentos convencionales. La fitoterapia ha demostrado su eficacia en la prevención de la EA, destacando el Aloe Vera por sus beneficios.Objetivo: analisar os impactos na qualidade de vida dos pacientes de idade até 12 anos com dermatite atópica e quais os principais medicamentos utilizados. Métodos: Foi utilizado uma revisão integrativa de literatura, utilizando como pergunta norteadora; “Quais os impactos na qualidade de vida dos pacientes de idade até 12 anos com dermatite atópica e quais os principais medicamentos utilizados?”. Resultados: o artigo obteve como resultado a seleção de 11 artigos dos quais mais da metade trata da diminuição da qualidade e os demais de novos tratamentos de DA. Conclusão: Pode-se constatar diminuição na qualidade de vida das crianças e dos pais, provocando ainda danos psicológicos e sociais. Novas alternativas, como Duplilumabe vem obtendo bons resultados como uma alternativa ao tratamento de DA é utilizado quando a DA não é controlada por outros tratamentos convencionais ou quando em alguns casos os medicamentos convencionais não são indicados. Medicamento fitoterápico demonstraram eficacia na prevenção do quadro de DA, destacando-se o Aloe Vera devido aos seus benefícios.Research, Society and Development2021-11-20info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://rsdjournal.org/index.php/rsd/article/view/2271510.33448/rsd-v10i15.22715Research, Society and Development; Vol. 10 No. 15; e307101522715Research, Society and Development; Vol. 10 Núm. 15; e307101522715Research, Society and Development; v. 10 n. 15; e3071015227152525-3409reponame:Research, Society and Developmentinstname:Universidade Federal de Itajubá (UNIFEI)instacron:UNIFEIporhttps://rsdjournal.org/index.php/rsd/article/view/22715/20057Copyright (c) 2021 Jessica da Silva Lima; Omero Martins Rodrigues Juniorhttps://creativecommons.org/licenses/by/4.0info:eu-repo/semantics/openAccessLima, Jessica da SilvaRodrigues Junior, Omero Martins2021-12-06T10:13:53Zoai:ojs.pkp.sfu.ca:article/22715Revistahttps://rsdjournal.org/index.php/rsd/indexPUBhttps://rsdjournal.org/index.php/rsd/oairsd.articles@gmail.com2525-34092525-3409opendoar:2024-01-17T09:41:48.290432Research, Society and Development - Universidade Federal de Itajubá (UNIFEI)false |
| dc.title.none.fl_str_mv |
Pharmacotherapeutic follow-up to pediatric patients aged up to 12 years in the pathology of atopic dermatitis - integrative review Seguimiento farmacoterapéutico de pacientes pediátricos de hasta 12 años en patología de la dermatitis atópica - revisión integradora Acompanhamento farmacoterapêutico ao paciente pediátrico na faixa etária de até 12 anos na patologia de dermatite atópica - revisão integrativa |
| title |
Pharmacotherapeutic follow-up to pediatric patients aged up to 12 years in the pathology of atopic dermatitis - integrative review |
| spellingShingle |
Pharmacotherapeutic follow-up to pediatric patients aged up to 12 years in the pathology of atopic dermatitis - integrative review Lima, Jessica da Silva Atopic dermatites New drugs Quality of life. Dermatitis atópica Nuevas drogas Calidad de vida. Dermatite atópica Novos medicamentos Qualidade de vida. |
| title_short |
Pharmacotherapeutic follow-up to pediatric patients aged up to 12 years in the pathology of atopic dermatitis - integrative review |
| title_full |
Pharmacotherapeutic follow-up to pediatric patients aged up to 12 years in the pathology of atopic dermatitis - integrative review |
| title_fullStr |
Pharmacotherapeutic follow-up to pediatric patients aged up to 12 years in the pathology of atopic dermatitis - integrative review |
| title_full_unstemmed |
Pharmacotherapeutic follow-up to pediatric patients aged up to 12 years in the pathology of atopic dermatitis - integrative review |
| title_sort |
Pharmacotherapeutic follow-up to pediatric patients aged up to 12 years in the pathology of atopic dermatitis - integrative review |
| author |
Lima, Jessica da Silva |
| author_facet |
Lima, Jessica da Silva Rodrigues Junior, Omero Martins |
| author_role |
author |
| author2 |
Rodrigues Junior, Omero Martins |
| author2_role |
author |
| dc.contributor.author.fl_str_mv |
Lima, Jessica da Silva Rodrigues Junior, Omero Martins |
| dc.subject.por.fl_str_mv |
Atopic dermatites New drugs Quality of life. Dermatitis atópica Nuevas drogas Calidad de vida. Dermatite atópica Novos medicamentos Qualidade de vida. |
| topic |
Atopic dermatites New drugs Quality of life. Dermatitis atópica Nuevas drogas Calidad de vida. Dermatite atópica Novos medicamentos Qualidade de vida. |
| description |
Objective: to analyze the impacts on the quality of life of patients aged up to 12 years with atopic dermatitis and which are the main drugs used. Methods: An integrative literature review was used, using as a guiding question; “What are the impacts on the quality of life of patients aged up to 12 years with atopic dermatitis and what are the main drugs used?”. Results: the article resulted in the selection of 11 articles, of which more than half deal with reduced quality and the rest with new AD treatments. Conclusion: It can be seen a decrease in the quality of life of children and parents, also causing psychological and social damage. New alternatives such as Duplilumabe have been obtaining good results as an alternative to the treatment of AD is used when AD is not controlled by other conventional treatments or when in some cases conventional medications are not indicated. Herbal medicine demonstrated effectiveness in preventing AD, with Aloe Vera standing out due to its benefits. |
| publishDate |
2021 |
| dc.date.none.fl_str_mv |
2021-11-20 |
| dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion |
| format |
article |
| status_str |
publishedVersion |
| dc.identifier.uri.fl_str_mv |
https://rsdjournal.org/index.php/rsd/article/view/22715 10.33448/rsd-v10i15.22715 |
| url |
https://rsdjournal.org/index.php/rsd/article/view/22715 |
| identifier_str_mv |
10.33448/rsd-v10i15.22715 |
| dc.language.iso.fl_str_mv |
por |
| language |
por |
| dc.relation.none.fl_str_mv |
https://rsdjournal.org/index.php/rsd/article/view/22715/20057 |
| dc.rights.driver.fl_str_mv |
Copyright (c) 2021 Jessica da Silva Lima; Omero Martins Rodrigues Junior https://creativecommons.org/licenses/by/4.0 info:eu-repo/semantics/openAccess |
| rights_invalid_str_mv |
Copyright (c) 2021 Jessica da Silva Lima; Omero Martins Rodrigues Junior https://creativecommons.org/licenses/by/4.0 |
| eu_rights_str_mv |
openAccess |
| dc.format.none.fl_str_mv |
application/pdf |
| dc.publisher.none.fl_str_mv |
Research, Society and Development |
| publisher.none.fl_str_mv |
Research, Society and Development |
| dc.source.none.fl_str_mv |
Research, Society and Development; Vol. 10 No. 15; e307101522715 Research, Society and Development; Vol. 10 Núm. 15; e307101522715 Research, Society and Development; v. 10 n. 15; e307101522715 2525-3409 reponame:Research, Society and Development instname:Universidade Federal de Itajubá (UNIFEI) instacron:UNIFEI |
| instname_str |
Universidade Federal de Itajubá (UNIFEI) |
| instacron_str |
UNIFEI |
| institution |
UNIFEI |
| reponame_str |
Research, Society and Development |
| collection |
Research, Society and Development |
| repository.name.fl_str_mv |
Research, Society and Development - Universidade Federal de Itajubá (UNIFEI) |
| repository.mail.fl_str_mv |
rsd.articles@gmail.com |
| _version_ |
1797052758662053888 |